Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices 52065 

although the BSC will receive public 

comments only during the formal public 

comment periods, which are indicated 

on the preliminary agenda. Each 

organization is allowed one time slot 

per agenda topic. Each speaker is 

allotted at least 7 minutes, which if time 

permits, may be extended to 10 minutes 

at the discretion of the BSC chair. 

Persons wishing to present oral 

comments should register on the BSC 

meeting Web site by November 30, 

2017, indicate whether they will present 

comments in-person or via the 

teleconference line, and indicate the 

topic(s) on which they plan to comment. 

The access number for the 

teleconference line will be provided to 

registrants by email prior to the meeting. 

On-site registration for oral comments 

will also be available on the meeting 

day, although time allowed for 

comments by these registrants may be 

limited and will be determined by the 

number of persons who register at the 

meeting. 

Persons registering to make oral 

comments are asked to send a copy of 

their statement and/or PowerPoint 

slides to the Designated Federal Officer 

by November 30, 2017. Written 

statements can supplement and may 

expand upon the oral presentation. If 

registering on-site and reading from 

written text, please bring 20 copies of 

the statement for distribution to the BSC 

and NTP staff and to supplement the 

record. 

Background Information on the BSC: 

The BSC is a technical advisory body 

comprised of scientists from the public 

and private sectors that provides 

primary scientific oversight to the NTP. 

Specifically, the BSC advises the NTP 

on matters of scientific program content, 

both present and future, and conducts 

periodic review of the program for the 

purpose of determining and advising on 

the scientific merit of its activities and 

their overall scientific quality. Its 

members are selected from recognized 

authorities knowledgeable in fields such 

as toxicology, pharmacology, pathology, 

biochemistry, epidemiology, risk 

assessment, carcinogenesis, 

mutagenesis, molecular biology, 

behavioral toxicology, neurotoxicology, 

immunotoxicology, reproductive 

toxicology or teratology, and 

biostatistics. Members serve overlapping 

terms of up to four years. The BSC 

usually meets biannually. The authority 

for the BSC is provided by 42 U.S.C. 

217a, section 222 of the Public Health 

Service Act (PHS), as amended. 

The BSC is governed by the 

provisions of the Federal Advisory 

Committee Act, as amended (5 U.S.C. 

app.), which sets forth standards for the 

formation and use of advisory 

committees. 

Dated: November 1, 2017. 

John R. Bucher, 

Associate Director, National Toxicology 

Program. 

[FR Doc. 2017–24401 Filed 11–8–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

National Cancer Institute; Notice of 

Meeting 

Pursuant to section 10(d) of the 

Federal Advisory Committee Act, as 

amended, notice is hereby given of the 

joint meeting of the NCI Board of 

Scientific Advisors (BSA) and National 

Cancer Advisory Board (NCAB). 

The meeting will be open to the 

public as indicated below, with 

attendance limited to space available. 

Individuals who plan to attend and 

need special assistance, such as sign 

language interpretation or other 

reasonable accommodations, should 

notify the Contact Person listed below 

in advance of the meeting. The open 

session will be videocast and can be 

accessed from the NIH Videocasting and 

Podcasting Web site (http://

videocast.nih.gov). 

A portion of the National Cancer 

Advisory Board meeting will be closed 

to the public in accordance with the 

provisions set forth in section 

552b(c)(6), Title 5 U.S.C., as amended, 

for the review, discussion, and 

evaluation of individual intramural 

programs and projects conducted by the 

National Cancer Institute, including 

consideration of personnel 

qualifications and performance, and the 

competence of individual investigators, 

the disclosure of which would 

constitute a clearly unwarranted 

invasion of personal privacy. 

Name of Committee: National Cancer 

Advisory Board, Ad Hoc Subcommittee on 

Global Cancer Research. 

Open: November 28, 2017, 5:30 p.m. to 

7:00 p.m. 

Agenda: Discussion on Global Cancer 

Research. 

Place: Gaithersburg Marriott 

Washingtonian Center, Lakeside Conference 

Room 1 and 2, 9751 Washington Boulevard, 

Gaithersburg, MD 20878. 

Contact Person: Dr. Edward Trimble, 

Executive Secretary, NCAB Ad Hoc 

Subcommittee on Global Cancer Research, 

National Cancer Institute—Shady Grove, 

National Institutes of Health, 9609 Medical 

Center Drive, Room 3W562, Bethesda, MD 

20892, (240) 276–5796, trimblet@

mail.nih.gov. 

Name of Committee: National Cancer 

Advisory Board, Ad Hoc Subcommittee on 

Population Science, Epidemiology and 

Disparities. 

Open: November 28, 2017, 7:30 p.m. to 

9:00 p.m. 

Agenda: Discussion on Population Science, 

Epidemiology and Disparities. 

Place: Gaithersburg Marriott 

Washingtonian Center, Lakeside Conference 

Room 1 and 2, 9751 Washington Boulevard, 

Gaithersburg, MD 20878. 

Contact Person: Dr. Deborah Winn, 

Executive Secretary, NCAB Ad Hoc 

Subcommittee on Population Science, 

Epidemiology and Disparities, National 

Cancer Institute—Shady Grove, National 

Institutes of Health, 9609 Medical Center 

Drive, Room 4E344, Bethesda, MD 20892, 

(240) 276–6755, winnde@mail.nih.gov. 

Name of Committee: NCI Board of 

Scientific Advisors and National Cancer 

Advisory Board. 

Open: November 29, 2017, 8:30 a.m. to 

4:00 p.m. 

Agenda: Joint meeting of the NCI Board of 

Scientific Advisors and National Cancer 

Advisory Board; NCI Director’s report and 

presentations, NCI Board of Scientific 

Advisors Concepts Review. 

Closed: November 29, 2017, 4:30 p.m. to 

5:30 p.m. 

Agenda: Review of intramural program site 

visit outcomes and the discussion of 

confidential personnel issues. 

Place: National Cancer Institute—Shady 

Grove, 9609 Medical Center Drive, Room 

TE406 & 408, Rockville, MD 20850. 

Contact Person: Paulette S. Gray, Ph.D., 

Director, Division of Extramural Activities, 

National Cancer Institute—Shady Grove, 

National Institutes of Health, 9609 Medical 

Center Drive, Room 7W444, Bethesda, MD 

20892, 240–276–6340, grayp@mail.nih.gov. 

Any interested person may file written 

comments with the committee by forwarding 

the statement to the Contact Person listed on 

this notice. The statement should include the 

name, address, telephone number and when 

applicable, the business or professional 

affiliation of the interested person. 

In the interest of security, NIH has 

instituted stringent procedures for entrance 

onto the NCI-Shady Grove campus. All 

visitors will be asked to show one form of 

identification (for example, a governmentissued photo ID, driver’s license, or passport) 

and to state the purpose of their visit. 

Information is also available on the 

Institute’s/Center’s home page: NCAB: http:// 

deainfo.nci.nih.gov/advisory/ncab/ncab.htm, 

BSA: http://deainfo.nci.nih.gov/advisory/bsa/ 

bsa.htm, where an agenda and any additional 

information for the meeting will be posted 

when available. 

(Catalogue of Federal Domestic Assistance 

Program Nos. 93.392, Cancer Construction; 

93.393, Cancer Cause and Prevention 

Research; 93.394, Cancer Detection and 

Diagnosis Research; 93.395, Cancer 

Treatment Research; 93.396, Cancer Biology 

Research; 93.397, Cancer Centers Support; 

93.398, Cancer Research Manpower; 93.399, 

Cancer Control, National Institutes of Health, 

HHS) 


sradovich on DSK3GMQ082PROD with NOTICES
52066 Federal Register / Vol. 82, No. 216 / Thursday, November 9, 2017 / Notices 

Dated: November 6, 2017. 

Melanie J. Pantoja, 

Program Analyst, Office of Federal Advisory 

Committee Policy. 

[FR Doc. 2017–24402 Filed 11–8–17; 8:45 am] 

BILLING CODE 4140–01–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

National Institutes of Health 

Draft Report on Carcinogens 

Monograph on Antimony Trioxide; 

Availability of Document; Request for 

Comments; Notice of Peer-Review 

Meeting 

AGENCY: National Institutes of Health, 

HHS. 

ACTION: Notice. 

SUMMARY: The National Toxicology 

Program (NTP) announces a meeting to 

peer review the Draft Report on 

Carcinogens (RoC) Monograph on 

Antimony Trioxide. The Office of the 

Report on Carcinogens, Division of the 

National Toxicology Program (DNTP), 

National Institute of Environmental 

Health Sciences (NIEHS) prepared the 

monograph. This peer-review meeting is 

by webcast only and is open to the 

public. Registration is requested for oral 

comment and is required to access the 

webcast. Information about the meeting 

and registration is available at https://

ntp.niehs.nih.gov/go/38853. 

DATES:

Meeting: January 24, 2018, 8:30 a.m. 

to adjournment at approximately 4:00 

p.m. Eastern Standard Time (EST). The 

meeting may end sooner or later than 

4:00 p.m. EST. 

Document Availability: The draft 

monograph should be available by 

November 30, 2017, at https://

ntp.niehs.nih.gov/go/38853. 

Written Public Comment 

Submissions: Deadline is January 10, 

2018. 

Registration for Oral Comments: 

Deadline is January 10, 2018. 

Registration to View Webcast: 

Deadline is January 24, 2018. 

Registration to view the meeting 

webcast is required. 

ADDRESSES: 

Meeting Location: Webcast. 

Meeting Web page: The draft 

monograph, preliminary agenda, 

registration, and other meeting materials 

will be available at https://

ntp.niehs.nih.gov/go/38853. 

Webcast: The URL for viewing the 

peer-review meeting webcast will be 

provided to registrants. 

FOR FURTHER INFORMATION CONTACT: 

Canden Byrd, ICF, 2635 Meridian 

Parkway, Suite 200, Durham, NC, USA 

27713. Phone: (919) 293–1660, Fax: 

(919) 293–1645, Email: canden.byrd@

icf.com. 

SUPPLEMENTARY INFORMATION: 

Background: The RoC is a 

congressionally mandated, sciencebased, public health report that 

identifies agents, substances, mixtures, 

or exposures (collectively called 

‘‘substances’’) in our environment that 

pose a cancer hazard for people in the 

United States. NTP prepares the RoC on 

behalf of the Secretary of Health and 

Human Services. 

NTP follows an established, four-part 

process for preparing the RoC (https:// 

ntp.niehs.nih.gov/pubhealth/roc/ 

process/index.html). For each substance 

selected for review, a draft RoC 

monograph is prepared that presents (1) 

information on human exposure to the 

substance; (2) an assessment of the 

evidence from cancer studies in humans 

and experimental animals, mechanisms 

of carcinogenicity, and other data 

relevant for evaluating the substance’s 

potential carcinogenicity; and (3) NTP’s 

preliminary RoC listing 

recommendation. The draft monograph 

also contains a draft profile that 

provides NTP’s preliminary listing 

recommendation for the substance and 

a summary of the scientific evidence 

considered key to reaching that 

recommendation. 

Antimony trioxide was selected for 

review following solicitation of public 

comment, review by the NTP Board of 

Scientific Counselors on December 14– 

15, 2016, and approval by the NTP 

Director (https://ntp.niehs.nih.gov/go/ 

9741). 

Antimony trioxide is the most 

commercially significant form of 

antimony and is a high-productionvolume chemical with a production 

volume exceeding one million pounds 

per year. Its major industrial use is as a 

synergist with halogenated flameretardants in textiles, plastics, and 

rubber. The main exposures to antimony 

trioxide are from inhalation of airborne 

solid dust and for workers in facilities 

producing or using antimony trioxide. 

Exposures of the public to antimony 

trioxide are primarily from 

environmental exposures secondary to 

human activities. Antimony trioxide can 

form in the product life cycle of other 

antimony compounds, such as during 

the use of automobile brake containing 

antimony trisulfate, which can oxidize 

into antimony trioxide. The draft RoC 

monograph includes a cancer hazard 

assessment of antimony trioxide. 

Meeting and Registration: The 

meeting is open to the public with time 

set aside for oral public comment. 

Registration to view the webcast is by 

January 24, 2018, at https://

ntp.niehs.nih.gov/go/38853. Registration 

is required to view the webcast; the URL 

for the webcast will be provided in the 

email confirming registration. 

Individuals with disabilities who need 

accommodation to view the webcast 

should contact Canden Byrd by phone: 

(919) 293–1660 or email: canden.byrd@

icf.com. TTY users should contact the 

Federal TTY Relay Service at (800) 877– 

8339. Requests should be made at least 

five business days in advance of the 

event. 

Meeting Materials: The draft 

monograph and preliminary agenda will 

be available on the NTP Web site at 

https://ntp.niehs.nih.gov/go/38853. The 

draft monograph should be available by 

November 30, 2017. Additional 

information will be posted when 

available or may be requested in 

hardcopy, contact Canden Byrd by 

phone: (919) 293–1660 or email: 

canden.byrd@icf.com. 

Following the meeting, a report of the 

peer review will be prepared and made 

available on the NTP Web site. 

Individuals are encouraged to access the 

meeting Web page to stay abreast of the 

most current information regarding the 

meeting. 

Request for Comments: NTP invites 

written and oral public comments on 

the draft monograph. The deadline for 

submission of written comments is 

January 10, 2018, to enable review by 

the peer-review panel and NTP staff 

prior to the meeting. Registration to 

provide oral comments is on or before 

January 10, 2018, at https://

ntp.niehs.nih.gov/go/38853. Written 

public comments and any other 

correspondence on the draft monograph 

should be sent to Canden Byrd by email: 

canden.byrd@icf.com. Persons 

submitting written comments should 

include name, affiliation, mailing 

address, phone, email, and sponsoring 

organization (if any). Written comments 

received in response to this notice will 

be posted on the NTP Web site, and the 

submitter will be identified by name, 

affiliation, and sponsoring organization 

(if any). Guidelines for public comments 

are available at https://

ntp.niehs.nih.gov/ntp/about_ntp/ 

guidelines_public_comments_508.pdf. 

Oral public comment at this meeting 

is welcome, with time set aside on 

January 24 for the presentation of oral 

remarks on the draft monograph. Public 

comments will be presented by 

teleconference line. Fifty (50) lines will 

be available for this call; availability is 

on a first-come, first-served basis. The 

lines will be open from 8:30 a.m. until 


sradovich on DSK3GMQ082PROD with NOTICES